02.12.2021 11:20
Medimaps Group, a global company headquartered in Switzerland, is specialized in image processing software for the assessment of bone health. The company’s current flagship product, Trabecular Bone Score (TBS iNsight), has received medical reimbursement in the U.S. beginning January 1, 2022. The funds raised will be used to expand its product portfolio with the development and market in the U.S., Europe, Asia, and Latin America.